Disruption of Cytochrome C Heme Coordination is Responsible for Mitochondrial Injury During Ischemia

Overview

Journal Biochim Biophys Acta

Specialties Biochemistry
Biophysics

Date 2015 Jun 14

PMID 26071084

Citations 34

Authors

Alexander V Birk

Wesley M Chao

Shaoyi Liu

Yi Soong

Hazel H Szeto

Affiliations

Soon will be listed here.

Abstract

Background: It was recently suggested that electron flow into cyt c, coupled with ROS generation, oxidizes cyt c Met(80) to Met(80) sulfoxide (Met-O) in isolated hearts after ischemia-reperfusion, and converts cyt c to a peroxidase. We hypothesize that ischemia disrupts Met(80)-Fe ligation of cyt c, forming pentacoordinated heme Fe(2+), which inhibits electron transport (ET) and promotes oxygenase activity.

Methods: SS-20 (Phe-D-Arg-Phe-Lys-NH2) was used to demonstrate the role of Met(80)-Fe ligation in ischemia. Mitochondria were isolated from ischemic rat kidneys to determine sites of respiratory inhibition. Mitochondrial cyt c and cyt c Met-O were quantified by western blot, and cristae architecture was examined by electron microscopy.

Results: Biochemical and structural studies showed that SS-20 selectively targets cardiolipin (CL) and protects Met(80)-Fe ligation in cyt c. Ischemic mitochondria showed 17-fold increase in Met-O cyt c, and dramatic cristaeolysis. Loss of cyt c was associated with proteolytic degradation of OPA1. Ischemia significantly inhibited ET initiated by direct reduction of cyt c and coupled respiration. All changes were prevented by SS-20.

Conclusion: Our results show that ischemia disrupts the Met(80)-Fe ligation of cyt c resulting in the formation of a globin-like pentacoordinated heme Fe(2+) that inhibits ET, and converts cyt c into an oxygenase to cause CL peroxidation and proteolytic degradation of OPA1, resulting in cyt c release.

General Significance: Cyt c heme structure represents a novel target for minimizing ischemic injury. SS-20, which we show to selectively target CL and protect the Met(80)-Fe ligation, minimizes ischemic injury and promotes ATP recovery.

Citing Articles

Mitochondrial destabilization in tendinopathy and potential therapeutic strategies.

Cheng L, Zheng Q, Qiu K, Ker D, Chen X, Yin Z J Orthop Translat. 2024; 49:49-61.

PMID: 39430132 PMC: 11488423. DOI: 10.1016/j.jot.2024.09.003.

Mitophagy in atherosclerosis: from mechanism to therapy.

Zhang Y, Weng J, Huan L, Sheng S, Xu F Front Immunol. 2023; 14:1165507.

PMID: 37261351 PMC: 10228545. DOI: 10.3389/fimmu.2023.1165507.

Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy.

Itoh K, Shimoyama M, Schiller P, Toyama S Chem Biol Drug Des. 2022; 101(4):1012-1018.

PMID: 36513390 PMC: 10064869. DOI: 10.1111/cbdd.14192.

Structure-activity relationships of mitochondria-targeted tetrapeptide pharmacological compounds.

Mitchell W, Tamucci J, Ng E, Liu S, Birk A, Szeto H Elife. 2022; 11.

PMID: 35913044 PMC: 9342957. DOI: 10.7554/eLife.75531.

Treatment of age-related visual impairment with a peptide acting on mitochondria.

Alam N, Douglas R, Prusky G Dis Model Mech. 2021; 15(3).

PMID: 34766182 PMC: 8891924. DOI: 10.1242/dmm.048256.

References

Ishihara N, Fujita Y, Oka T, Mihara K . Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 2006; 25(13):2966-77. PMC: 1500981. DOI: 10.1038/sj.emboj.7601184. View

Cipolat S, Rudka T, Hartmann D, Costa V, Serneels L, Craessaerts K . Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell. 2006; 126(1):163-75. DOI: 10.1016/j.cell.2006.06.021. View

Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko G, Rudka T . OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006; 126(1):177-89. DOI: 10.1016/j.cell.2006.06.025. View

Vladimirov Y, Proskurnina E, Izmailov D, Novikov A, Brusnichkin A, Osipov A . Mechanism of activation of cytochrome C peroxidase activity by cardiolipin. Biochemistry (Mosc). 2006; 71(9):989-97. DOI: 10.1134/s0006297906090070. View

Basova L, Kurnikov I, Wang L, Ritov V, Belikova N, Vlasova I . Cardiolipin switch in mitochondria: shutting off the reduction of cytochrome c and turning on the peroxidase activity. Biochemistry. 2007; 46(11):3423-34. PMC: 3356783. DOI: 10.1021/bi061854k. View

Song Z, Chen H, Fiket M, Alexander C, Chan D . OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol. 2007; 178(5):749-55. PMC: 2064540. DOI: 10.1083/jcb.200704110. View

Griparic L, Kanazawa T, van der Bliek A . Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage. J Cell Biol. 2007; 178(5):757-64. PMC: 2064541. DOI: 10.1083/jcb.200704112. View

Chen Q, Moghaddas S, Hoppel C, Lesnefsky E . Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol. 2007; 294(2):C460-6. DOI: 10.1152/ajpcell.00211.2007. View

Szeto H . Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal. 2007; 10(3):601-19. DOI: 10.1089/ars.2007.1892. View

10.

Sinibaldi F, Howes B, Piro M, Polticelli F, Bombelli C, Ferri T . Extended cardiolipin anchorage to cytochrome c: a model for protein-mitochondrial membrane binding. J Biol Inorg Chem. 2010; 15(5):689-700. DOI: 10.1007/s00775-010-0636-z. View

11.

Chen Q, Yin G, Stewart S, Hu Y, Lesnefsky E . Isolating the segment of the mitochondrial electron transport chain responsible for mitochondrial damage during cardiac ischemia. Biochem Biophys Res Commun. 2010; 397(4):656-60. PMC: 3045679. DOI: 10.1016/j.bbrc.2010.05.137. View

12.

Szeto H, Liu S, Soong Y, Wu D, Darrah S, Cheng F . Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol. 2011; 22(6):1041-52. PMC: 3103724. DOI: 10.1681/ASN.2010080808. View

13.

Sinibaldi F, Droghetti E, Polticelli F, Piro M, Pierro D, Ferri T . The effects of ATP and sodium chloride on the cytochrome c-cardiolipin interaction: the contrasting behavior of the horse heart and yeast proteins. J Inorg Biochem. 2011; 105(11):1365-72. DOI: 10.1016/j.jinorgbio.2011.07.022. View

14.

Bradley J, Silkstone G, Wilson M, Cheesman M, Butt J . Probing a complex of cytochrome c and cardiolipin by magnetic circular dichroism spectroscopy: implications for the initial events in apoptosis. J Am Chem Soc. 2011; 133(49):19676-9. DOI: 10.1021/ja209144h. View

15.

Musatov A, Fabian M, Varhac R . Elucidating the mechanism of ferrocytochrome c heme disruption by peroxidized cardiolipin. J Biol Inorg Chem. 2012; 18(1):137-44. PMC: 3536883. DOI: 10.1007/s00775-012-0958-0. View

16.

Snider E, Muenzner J, Toffey J, Hong Y, Pletneva E . Multifaceted effects of ATP on cardiolipin-bound cytochrome c. Biochemistry. 2013; 52(6):993-5. PMC: 3658621. DOI: 10.1021/bi301682c. View

17.

Josephs T, Liptak M, Hughes G, Lo A, Smith R, Wilbanks S . Conformational change and human cytochrome c function: mutation of residue 41 modulates caspase activation and destabilizes Met-80 coordination. J Biol Inorg Chem. 2013; 18(3):289-97. PMC: 3582831. DOI: 10.1007/s00775-012-0973-1. View

18.

Soffer J, Fradkin E, Pandiscia L, Schweitzer-Stenner R . The (not completely irreversible) population of a misfolded state of cytochrome c under folding conditions. Biochemistry. 2013; 52(8):1397-408. DOI: 10.1021/bi301586e. View

19.

Pohlmann A, Cantow K, Hentschel J, Arakelyan K, Ladwig M, Flemming B . Linking non-invasive parametric MRI with invasive physiological measurements (MR-PHYSIOL): towards a hybrid and integrated approach for investigation of acute kidney injury in rats. Acta Physiol (Oxf). 2013; 207(4):673-89. DOI: 10.1111/apha.12065. View

20.

Birk A, Liu S, Soong Y, Mills W, Singh P, Warren J . The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 2013; 24(8):1250-61. PMC: 3736700. DOI: 10.1681/ASN.2012121216. View